As the strategic and operating environment for Pharmaceutical R&D becomes more cost-constrained and evolving portfolios require increasingly more investment, critical decision-making and methodology is evidently a crucial element in PPM.
Drug patents play a central role in the pharmaceutical industry. Fortunes change change overnight as innovators lose patent protection, and as generics start to gain market share. A challenge in navigating this exciting space is that it can be difficult to determine when drug patents expire, and when generics can launch. Differences in international patent […]